首页> 外国专利> DIPHENYLAMINE DERIVATIVES: APPLICATION, METHOD OF SYNTHESIS AND FRAMACEUTICAL COMPOSITIONS

DIPHENYLAMINE DERIVATIVES: APPLICATION, METHOD OF SYNTHESIS AND FRAMACEUTICAL COMPOSITIONS

机译:二苯胺衍生物:应用,合成方法和骨架组成

摘要

1. The compound of formula (I) or its salt, prodrug or solvate: where Ph is phenyl; n is 2, 3 or 4; R is selected from the group consisting of hydrogen and C 1-6 alkyl; R is a radical of the formula - [[CH (R) ] -R], where m is 1; R, where provided, is selected from the group consisting of hydrogen, phenyl and C-C1-6 alkyl; R is selected from the group consisting of radicals: unsubstituted heteroaryl, substituted heteroaryl and substituted aryl, wherein these substituents are selected from a group consisting of C 1-6 alkyl, C 1-6 arylalkyl, phenyl, 5- or 6-membered heteroaryl, F, Cl, Br, I, trifluoromethyl, cyano, —N (R) (R), —OR, —SR, or —C ( O) R; where R, R, R, R and R are independently selected from a hydrogen atom, C 1-6 alkyl, phenyl and trifluoromethyl; or if R and / or R are different from a hydrogen atom, then R may also mean unsubstituted phenyl; or R and R, together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heteroaryl group in which the indicated substituents are as defined above, provided that: 2 - [(4,4-diphenylbut-3-enylamino) methyl] phenol 3 - [(4,4-diphenylbut-3-enylamino) methyl] phenol, 5 - [(4,4-diphenylbut-3-enylamino) methyl] -2-methoxyphenol, 4 - [(4,4-diphenylbut -3-enylamino) methyl] -2,6-difluorophenol, benzyl- (5,5-diphenylpent-4-enyl) ethylamine, 6-chloro-9- (4,4-diphenylbut-3-enyl) -9H-purine , 9- (4,4-diphenylbut-3-enyl) -9H-purin-6-ylamine, and 5- (4,4-diphenylbut-3-enyl) -4,5,6,7-tetrahydroisoxazolo [4,5 -c] pyridin-3-o l are not included in formula (I) .2. The compound according to claim 1, where each of these substituents is selected from the group consisting of C 1-6 alkyl, C 1-6 arylalkyl, phenyl, 5- or 6-membered heteroaryl, F, Br, I, trifluoromethyl, cyano, —N (R) ( R), —OR, —SR or —C (O) R; where R, R, R and R are independently selected from a hydrogen atom, C-C1-6 alkyl, phenyl and trifluoromethyl, and R is selected from the group consisting of C-C1-6 alkyl, phenyl and trifluoromethyl, provided that -N (R) (R) is not
机译:1.式(I)化合物或其盐,前药或溶剂化物:其中Ph为苯基; n为2、3或4; R选自氢和C 1-6烷基; R是式-[[CH(R)]-R]的基团,其中m是1;如果提供的话,R选自氢,苯基和C 1 -C 1-6烷基; R选自基团:未取代的杂芳基,取代的杂芳基和取代的芳基,其中这些取代基选自C 1-6烷基,C 1-6芳基烷基,苯基,5-或6-元杂芳基,F,Cl,Br,I,三氟甲基,氰基,-N(R)(R),-OR,-SR或-C(O)R;其中R 1,R 2,R 3,R 5和R 6独立地选自氢原子,C 1-6烷基,苯基和三氟甲基;或者如果R和/或R与氢原子不同,则R也可以表示未取代的苯基;或R 1和R 2与它们所连接的氮原子一起形成取代或未取代的杂芳基,其中所示的取代基如上所定义,条件是:2-[(4,4-二苯基丁-3-烯基氨基)甲基]苯酚3-[[(4,4-二苯基丁-3-烯基氨基)甲基]苯酚,5-[(4,4-二苯基丁-3-烯基氨基)甲基] -2-甲氧基苯酚,4-[(4,4- [二苯基丁-3-烯氨基)甲基] -2,6-二氟苯酚,苄基-(5,5-二苯基戊-4-烯基)乙胺,6-氯-9-(4,4-二苯基丁-3-烯基)-9H-嘌呤,9-(4,4-二苯基丁-3-烯基)-9H-嘌呤-6-基胺和5-(4,4-二苯基丁-3-烯基)-4,5,6,7-四氢异恶唑[4 ,(5 -c]吡啶-3-醇不包括在式(I).2中。 2.根据权利要求1的化合物,其中这些取代基各自选自C 1-6烷基,C 1-6芳烷基,苯基,5-或6-元杂芳基,F,Br,I,三氟甲基,氰基,-N(R)(R),-OR,-SR或-C(O)R;其中R,R,R和R独立地选自氢原子,C-C1-6烷基,苯基和三氟甲基,并且R选自C-C1-6烷基,苯基和三氟甲基,条件是- N(R)(R)不是

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号